Literature DB >> 7543416

The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.

M Sattler1, M A Durstin, D A Frank, K Okuda, K Kaushansky, R Salgia, J D Griffin.   

Abstract

Thrombopoietin (TPO) is a growth and differentiation factor for megakaryocyte-lineage cells. The receptor for TPO, c-MPL, is a member of the hematopoietic cytokine receptor family and has previously been shown to rapidly activate one or more cytoplasmic tyrosine kinases after ligand binding. In this study, we found that activation of the TPO receptor rapidly induced tyrosine phosphorylation of two members of the Jak tyrosine kinase family, JAK2 and TYK2, but not JAK1 or JAK3, in two different factor-dependent hematopoietic cell lines. The activation of both JAK2 and TYK2 was dose- and time-dependent and was associated with rapid tyrosine phosphorylation of a series of STAT proteins including STAT1, STAT3, and STAT5. Gel-shift assays indicated that one or more of these STATs is likely to participate in the formation of specific DNA-binding complexes. The activation of tyrosine kinases and signal propagation through tyrosine phosphorylation are likely to represent important initial steps in mediating the activities of TPO in myeloid cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543416

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  30 in total

1.  BCR/ABL induces multiple abnormalities of cytoskeletal function.

Authors:  R Salgia; J L Li; D S Ewaniuk; W Pear; E Pisick; S A Burky; T Ernst; M Sattler; L B Chen; J D Griffin
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.

Authors:  S M Luoh; E Stefanich; G Solar; H Steinmetz; T Lipari; T I Pestina; C W Jackson; F J de Sauvage
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

Review 3.  Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender.

Authors:  Jeffrey Patterson-Fortin; Alison R Moliterno
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 4.  STAT signaling in the pathogenesis and treatment of cancer.

Authors:  D A Frank
Journal:  Mol Med       Date:  1999-07       Impact factor: 6.354

5.  An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.

Authors:  Judith Staerk; Catherine Lacout; Takeshi Sato; Steven O Smith; William Vainchenker; Stefan N Constantinescu
Journal:  Blood       Date:  2005-10-25       Impact factor: 22.113

6.  BCR/ABL directly inhibits expression of SHIP, an SH2-containing polyinositol-5-phosphatase involved in the regulation of hematopoiesis.

Authors:  M Sattler; S Verma; C H Byrne; G Shrikhande; T Winkler; P A Algate; L R Rohrschneider; J D Griffin
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

Review 7.  Prospect of JAK2 inhibitor therapy in myeloproliferative neoplasms.

Authors:  Ehab Atallah; Srdan Verstovsek
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

8.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Authors:  Michael D Feese; Taro Tamada; Yoichi Kato; Yoshitake Maeda; Masako Hirose; Yasuko Matsukura; Hideki Shigematsu; Takanori Muto; Atsushi Matsumoto; Hiroshi Watarai; Kinya Ogami; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

9.  STAT1 promotes megakaryopoiesis downstream of GATA-1 in mice.

Authors:  Zan Huang; Terri D Richmond; Andrew G Muntean; Dwayne L Barber; Mitchell J Weiss; John D Crispino
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy.

Authors:  Donald J McCrann; Alexia Eliades; Maria Makitalo; Kuniharu Matsuno; Katya Ravid
Journal:  Blood       Date:  2009-05-26       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.